Skip To Main Content
Yixiang Lian on Muck Rack

Yixiang Lian

As seen in: Frontiers, BMC Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yixiang

Contact Yixiang, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

ZNF582 hypermethylation as a highly specific biomarker for triage of high-grade cervical lesions in HR-HPV positive women

|
By Yixiang Lian, Shali Jiang, Jiali Wang, Haijun Luo, Suran Jiang
| Frontiers
1 Introduction Persistent infection with high-risk human papillomavirus (HR-HPV) is the established primary cause of cervical cancer (CC), leading the World Health Organization (WHO) and many countries to recommend HR-HPV testing as the primary screening method due to its high sensitivity in detecting high-grade cervical intraepithelial neoplasia (CIN) and CC (1).
Open in Who Shared Issue with article?

Relationship between p16/ki67 immunoscores and PAX1/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women | BMC Cancer | Full Text

|
By Haijun Luo, Hong Tao, Yan Zhao, Zhigan Wang, Jing Zhou, Zirong Zhang, Shali Jiang, Yixiang Lian
| BMC Cancer Verified
In this retrospective study, HR-HPV-positive patients with cervicitis, CIN1, CIN2, CIN3, or squamous cell carcinoma (SCC) who were diagnosed via histopathological analysis (colposcopy biopsy) at Changsha Central Hospital from October 2022 to July 2023 were included in the study population. The inclusion criteria included (1) HR-HPV-positive and (2) agreeing to participate and signing informed consent.
Open in Who Shared Issue with article?
See all 2 articles